Celiprolol Hydrochloride

盐酸塞利洛尔

Report date: 2025/12/05 09:24:14
NME

Base Information

Drug NameCeliprolol Hydrochloride
Drug Alias Name盐酸赛利洛尔celiprololum塞利洛尔celiprololCordiax +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertensionEhlers-Danlos SyndromeAngina Pectoris
Global Approved IndicationsHypertensionAngina Pectoris
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypertensionEhlers-Danlos SyndromeAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC07AB08